The Latin America, Middle East and Africa Competent Cells Market is projected to witness market growth of 10.5% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Competent Cells Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $73.9 million by 2031. The Argentina market is showcasing a CAGR of 11.1% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9.4% during (2024 - 2031).
Emerging these cells market trends reflect ongoing advancements in biotechnology, genetic engineering, and research methodologies. These trends are shaping the future landscape of these cells by introducing new technologies, expanding applications, and addressing industry challenges. For example, adopting advanced gene editing tools, such as CRISPR/Cas systems and base editing technologies, is revolutionizing the market.
Also, there is a growing emphasis on synthetic biology approaches using these cells for metabolic engineering and producing bio-based chemicals, fuels, and pharmaceuticals. Engineered microbial strains with enhanced metabolic pathways and optimized biosynthetic capabilities are being developed to meet sustainability goals and industrial demands.
Expansion in the pharmaceutical sector often leads to increased investments in research and development. According to the National Library of Medicine, Saudi Arabia’s pharmaceutical drugs industry is expected to exhibit a growth rate of 7.3% during the forecast period (2020-2027), owing to increasing launches and approval of drugs.
Additionally, as the pharmaceutical industry grows in Saudi Arabia, there will be a higher demand for biopharmaceutical products. Brazilian universities and research institutions are pivotal in driving the demand for these cells through their active engagement in biotechnological research and collaborations with industry partners. For instance, Universities such as the University of São Paulo (USP), Federal University of Rio de Janeiro (UFRJ), and State University of Campinas (UNICAMP) are leaders in biotechnological research in Brazil. Hence, growing pharmaceutical industry and rising educational and research Institutions are propelling the growth of the market.
The Brazil market dominated the LAMEA Competent Cells Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $73.9 million by 2031. The Argentina market is showcasing a CAGR of 11.1% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9.4% during (2024 - 2031).
Emerging these cells market trends reflect ongoing advancements in biotechnology, genetic engineering, and research methodologies. These trends are shaping the future landscape of these cells by introducing new technologies, expanding applications, and addressing industry challenges. For example, adopting advanced gene editing tools, such as CRISPR/Cas systems and base editing technologies, is revolutionizing the market.
Also, there is a growing emphasis on synthetic biology approaches using these cells for metabolic engineering and producing bio-based chemicals, fuels, and pharmaceuticals. Engineered microbial strains with enhanced metabolic pathways and optimized biosynthetic capabilities are being developed to meet sustainability goals and industrial demands.
Expansion in the pharmaceutical sector often leads to increased investments in research and development. According to the National Library of Medicine, Saudi Arabia’s pharmaceutical drugs industry is expected to exhibit a growth rate of 7.3% during the forecast period (2020-2027), owing to increasing launches and approval of drugs.
Additionally, as the pharmaceutical industry grows in Saudi Arabia, there will be a higher demand for biopharmaceutical products. Brazilian universities and research institutions are pivotal in driving the demand for these cells through their active engagement in biotechnological research and collaborations with industry partners. For instance, Universities such as the University of São Paulo (USP), Federal University of Rio de Janeiro (UFRJ), and State University of Campinas (UNICAMP) are leaders in biotechnological research in Brazil. Hence, growing pharmaceutical industry and rising educational and research Institutions are propelling the growth of the market.
List of Key Companies Profiled
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- New England Biolabs, Inc.
- Qiagen N.V
- Hoffmann-La Roche Ltd.
- Takara Bio Inc. (Takara Holdings Inc.)
- Lonza Group Ltd. (Capsugel)
Market Report Segmentation
By Type- Chemically Competent Cells
- Electrocompetent Cells
- Ultracompetent Cells
- Cloning
- Protein Expression
- Mutagenesis
- Others
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Competent Cells Market by Type
Chapter 6. LAMEA Competent Cells Market by Application
Chapter 7. LAMEA Competent Cells Market by End-Use
Chapter 8. LAMEA Competent Cells Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- New England Biolabs, Inc.
- Qiagen N.V
- F. Hoffmann-La Roche Ltd.
- Takara Bio Inc. (Takara Holdings Inc.)
- Lonza Group Ltd. (Capsugel)
Methodology
LOADING...
